| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 03/02/2005 | EP1077698B1 Metabolites of ecteinascidin 743 |
| 03/02/2005 | CN1589307A Phosphorescent compounds and devices comprising the same |
| 03/02/2005 | CN1589262A Cyanoguanidine prodrugs |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/01/2005 | US6861527 Nitration in a static micromixer |
| 02/24/2005 | WO2005016891A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 02/24/2005 | WO2005016890A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/24/2005 | WO2005016889A1 Compounds having antiestrogenic and tissue selective estrogenic properties |
| 02/24/2005 | WO2005016876A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | WO2005016867A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | US20050043552 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043351 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 02/24/2005 | US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/24/2005 | CA2743534A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/23/2005 | EP1507764A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 02/23/2005 | EP1507763A1 Tetrahydroisoquinoline derivatives |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | CN1583725A Preparation of liensinine, isoliensinine and methylliensinine extracted from lotus seed |
| 02/23/2005 | CN1190427C Method for preparing pyrimidine derivative |
| 02/22/2005 | US6858735 Preparation of quinapril hydrochloride |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2004094386A8 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038027 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |
| 02/17/2005 | CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/16/2005 | EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/10/2005 | WO2005011697A2 Sulfonamide derivatives with activity on protein kinase a and b |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050031903 Multilayer; charge generating compound, charge transfer compound; blue phosphorescence |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1503989A1 Dopamine receptor modulators as antipsychotic agents |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1487795A4 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 02/09/2005 | EP0983999B1 Process for producing amide derivatives and intermediates |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1188121C Therapeutic substituted guanidines |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2004072102A3 Benzene acetamide compounds useful as serine protease inhibitors |
| 02/03/2005 | US20050027007 Allylamides useful in the treatment of alzheimer's disease |
| 02/02/2005 | EP1501804A1 Isoquinoline derivatives mao-b inhibitors |
| 02/02/2005 | EP1501803A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1187332C Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020623 5-Substituted isoquinoline derivatives |
| 01/27/2005 | US20050020597 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499319A1 Bicyclo 4.4.0 antiviral derivatives |
| 01/26/2005 | EP1499313A2 Heterocyclic derivatives as opioid receptor modulators |
| 01/26/2005 | CN1186325C Tetrahydroisoquinoline derivative kind addition salt for treating cardiac and cerebral vascular diseases and its prepn |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/20/2005 | WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 01/20/2005 | WO2005004868A1 Anti-coronavirus drug |
| 01/20/2005 | US20050014946 Substituted amino ketone compounds |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | CN1566099A Isoquinoline-1, 3, 4-trione compounds, preparation method and uses thereof |
| 01/19/2005 | CN1566098A Isoquinoline compound, preparation method and application of salt thereof |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/13/2005 | WO2004099129A3 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009864 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 01/13/2005 | US20050009863 Used for treating renal disorders such as acute or chronic renal failure, biliary function disorders, respiratory disorders such as snoring or sleep apneas and strokes. |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/12/2005 | EP1495009A2 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 01/12/2005 | EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1228043B1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 01/12/2005 | CN1562974A Method for synthesizing 1, 2, 3, 4 ramification of tetrahydro-isoquinoline |
| 01/12/2005 | CN1184298C Color-safe bleach boosters, composns. and laundry methods employing same |
| 01/11/2005 | US6841560 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/06/2005 | WO2004103967A3 Thiocarbamate inhibitors of alpha-4 integrins |
| 01/06/2005 | WO2004101528A3 Isoquinoline derivatives and their use as gfat inhibitors |